We are live on ! Find out more
Charles Schwab

Charles Schwab Portfolio holdings

AUM $654B
1-Year Est. Return 26.35%
 

Charles Schwab Corporation, founded in 1971 by Charles R. Schwab and headquartered in Westlake, Texas, is a leading financial services firm that revolutionized retail investing by offering low-cost brokerage services. Initially disrupting the industry with discount commissions, it has grown into a powerhouse providing a wide array of services, including trading platforms, robo-advisors, retirement accounts, and banking products, managing hundreds of billions in client assets. Known for its user-friendly technology and customer-centric approach, Schwab caters to individual investors, financial advisors, and institutions, notably expanding through its 2020 acquisition of TD Ameritrade. With a mission to democratize investing, Charles Schwab remains a dominant force in the shift toward accessible, self-directed wealth management.

This Fund
S&P 500
This Quarter Est. Return
+2.98%
1 Year Est. Return
+26.35%
3 Year Est. Return
+83.88%
5 Year Est. Return
+111.55%
10 Year Est. Return
+435.01%
AUM
$106B
AUM Growth
+$6.52B
Cap. Flow
+$4.41B
Cap. Flow %
4.14%
Top 10 Hldgs %
13.68%
Holding
3,236
New
179
Increased
2,227
Reduced
440
Closed
133

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$115M
2
AAPL icon
Apple
AAPL
+$95.4M
3
DXC icon
DXC Technology
DXC
+$91M
4
PFE icon
Pfizer
PFE
+$66.9M
5
JNJ icon
Johnson & Johnson
JNJ
+$60.4M

Sector Composition

Rank Sector Weight
1 Technology 14.68%
2 Financials 14.59%
3 Healthcare 13.17%
4 Industrials 11.08%
5 Consumer Discretionary 9.22%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
INFI
3151
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
-67,500
Closed -$219K
AGRX
3152
DELISTED
Agile Therapeutics
AGRX
-7
Closed -$44K
MYOV
3153
DELISTED
Myovant Sciences Ltd.
MYOV
-16,900
Closed -$199K
FSTX
3154
DELISTED
F-star Therapeutics, Inc. Common Stock
FSTX
-7,075
Closed -$252K
SRNE
3155
DELISTED
Sorrento Therapeutics, Inc.
SRNE
-39,855
Closed -$158K
NH
3156
DELISTED
NantHealth, Inc
NH
-987
Closed -$74K
AGTC
3157
DELISTED
Applied Genetic Technologies Corporation
AGTC
-17,400
Closed -$121K
MN
3158
DELISTED
MANNING & NAPIER, INC.
MN
-22,200
Closed -$127K
AMPE
3159
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
-235
Closed -$57K
USAK
3160
DELISTED
USA Truck Inc
USAK
-14,200
Closed -$105K
ALJJ
3161
DELISTED
ALJ Regional Holdings Inc
ALJJ
-28,500
Closed -$107K
AUTO
3162
DELISTED
AutoWeb, Inc. Common Stock
AUTO
-13,500
Closed -$170K
LUB
3163
DELISTED
Luby's Inc.
LUB
-34,600
Closed -$108K
ICBK
3164
DELISTED
County Bancorp, Inc. Common Stock
ICBK
-7,500
Closed -$218K
KDMN
3165
DELISTED
Kadmon Holdings, Inc.
KDMN
-18,500
Closed -$67K
CBMG
3166
DELISTED
Cellular Biomedicine Group, Inc.
CBMG
-22,709
Closed -$268K
PFNX
3167
DELISTED
Pfenex Inc.
PFNX
-23,397
Closed -$136K
SDRL
3168
DELISTED
Seadrill Limited Common Stock
SDRL
-10,736
Closed -$4.74M
QHC
3169
DELISTED
Quorum Health Corporation
QHC
-107,695
Closed -$586K
GNMX
3170
DELISTED
Aevi Genomic Medicine Inc
GNMX
-44,012
Closed -$82K
AAC
3171
DELISTED
AAC Holdings
AAC
-26,002
Closed -$222K
HLTH
3172
DELISTED
Nobilis Health Corp.
HLTH
-88,191
Closed -$150K
KONA
3173
DELISTED
Kona Grill, Inc.
KONA
-17,119
Closed -$108K
EGLT
3174
DELISTED
Egalet Corporation
EGLT
-35,600
Closed -$182K
ANTH
3175
DELISTED
Anthera Pharmaceuticals, Inc.
ANTH
-6,492
Closed -$23K

Similar funds

Charles Schwab's Q2 2017 Portfolio in Review

As of Q2 2017, Charles Schwab held 3,236 positions worth $106B, up 6.5% from $99.9B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Charles Schwab deployed $4.41B of net new capital in Q2 2017, opening 179 new positions and adding to 2,227 existing holdings. Its largest new stake was DXC Technology: 1,371,360 shares worth $91M.

By sector, the portfolio is most concentrated in Technology at 15% of assets, down from 15% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was HP, an estimated $50.3M trimmed.

  • Charles Schwab's largest Q2 2017 buy was DXC Technology: 1,371,360 shares worth $91M.
  • Charles Schwab added most to ExxonMobil in Q2 2017, an estimated $115M increase.
  • Charles Schwab's biggest Q2 2017 reduction was HP, cutting an estimated $50.3M.
  • Charles Schwab fully exited Yahoo Inc in Q2 2017, selling an estimated $121M.
  • Charles Schwab's ten largest holdings make up 14% of its $106B portfolio in Q2 2017.
  • Charles Schwab opened 179 new positions and closed 133 in Q2 2017.
  • Charles Schwab's portfolio value rose 6.5% quarter-over-quarter to $106B.

Based on Charles Schwab's 13F filing for Q2 2017, filed 2 Aug 2017.